Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
CALL
Doximity
DOCS
$4.41B
| $27.7M | ﹤0.01% |
476,900
+66,600
| +16% | +$4.21M |
|
1452
Under Armour
UAA
$2.2B
| $27.6M | ﹤0.01% |
4,415,523
+3,954,612
| +858% | +$29.4M |
|
1453
PUT
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.35B
| $27.6M | ﹤0.01% |
4,757
+1,973
| +71% | +$8.64M |
|
1454
CALL
Rocket Companies
RKT
$40.5B
| $27.6M | ﹤0.01% |
2,284,300
+1,000,100
| +78% | +$12.9M |
|
1455
CALL
Sable Offshore Corp
SOC
$904M
| $27.6M | ﹤0.01% |
1,086,100
+266,600
| +33% | +$6.83M |
|
|
SWTX
1456
DELISTED
SpringWorks Therapeutics
SWTX
| $27.5M | ﹤0.01% |
623,663
+486,638
| +355% | +$22.4M |
|
1457
Baker Hughes
BKR
$61.4B
| $27.5M | ﹤0.01% |
625,328
-474,771
| -43% | -$21.2M |
|
1458
CALL
Emcor
EME
$32.6B
| $27.5M | ﹤0.01% |
74,300
+5,400
| +8% | +$2.34M |
|
1459
Expedia Group
EXPE
$40.6B
| $27.4M | ﹤0.01% |
163,007
-101,968
| -38% | -$18.6M |
|
1460
CALL
T. Rowe Price
TROW
$24.1B
| $27.3M | ﹤0.01% |
297,300
-39,600
| -12% | -$4.18M |
|
1461
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
| $27.3M | ﹤0.01% |
51,191
+15,001
| +41% | +$8.52M |
|
1462
CALL
DaVita
DVA
$11.3B
| $27.3M | ﹤0.01% |
178,500
-162,800
| -48% | -$25.6M |
|
1463
CALL
Amphenol
APH
$196B
| $27.3M | ﹤0.01% |
416,000
+85,900
| +26% | +$5.86M |
|
1464
PUT
Argan
AGX
$6.32B
| $27.3M | ﹤0.01% |
207,800
+124,300
| +149% | +$17.3M |
|
1465
TransUnion
TRU
$16.3B
| $27.2M | ﹤0.01% |
328,051
+78,779
| +32% | +$7.2M |
|
1466
PUT
Southern Copper
SCCO
$186B
| $27.2M | ﹤0.01% |
308,701
+102,217
| +50% | +$9.07M |
|
1467
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.83B
| $27.2M | ﹤0.01% |
485,900
-332,800
| -41% | -$19.6M |
|
1468
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.67B
| $27.2M | ﹤0.01% |
2,182,188
+1,141,476
| +110% | +$21M |
|
1469
PUT
Citizens Financial Group
CFG
$29.4B
| $27.2M | ﹤0.01% |
663,000
+321,400
| +94% | +$14.3M |
|
1470
CALL
Royal Bank of Canada
RY
$288B
| $27.1M | ﹤0.01% |
240,400
-118,800
| -33% | -$14M |
|
1471
CALL
US Global Jets ETF
JETS
$808M
| $27M | ﹤0.01% |
1,302,300
-1,057,300
| -45% | -$25.9M |
|
1472
CALL
British American Tobacco
BTI
$122B
| $27M | ﹤0.01% |
653,700
-145,600
| -18% | -$5.72M |
|
1473
AngloGold Ashanti
AU
$62.4B
| $27M | ﹤0.01% |
728,043
+39,839
| +6% | +$1.22M |
|
1474
PUT
iShares MSCI China ETF
MCHI
$6.24B
| $27M | ﹤0.01% |
496,700
-31,900
| -6% | -$1.64M |
|
1475
PUT
UiPath
PATH
$8.63B
| $27M | ﹤0.01% |
2,621,200
+535,600
| +26% | +$6.89M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.